Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Andruska

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Opioid Management|December 19, 2019
Fentanyl analogue overdose: Key lessons in management in the synthetic opioid ageAmer Raheemullah, Neal Andruska
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 16, 2019
Cocaine Cessation for Levamisole-Induced Vasculitis: Treating the Underlying DiseaseAmer Raheemullah, Molly Melhem, Neal Andruska
Substance Use & Misuse|November 24, 2019
Improving Residency Education on Chronic Pain and Opioid Use Disorder: Evaluation of CDC Guideline-Based EducationAmer Raheemullah, Neal Andruska, Maryam Saeed, et al.
Molecular and Cellular Endocrinology|November 10, 2015
Anticipatory activation of the unfolded protein response by epidermal growth factor is required for immediate early gene expression and cell proliferationLiqun Yu, Neal Andruska, Xiaobin Zheng, et al.
BMJ Case Reports|October 11, 2018
Severe pneumonitis refractory to steroids following anti-PD-1 immunotherapyNeal Andruska, Lily Mahapatra, Carleigh Hebbard, et al.
Journal of Biomolecular Screening|October 11, 2013
High-throughput fluorescence anisotropy screen for inhibitors of the oncogenic mRNA binding protein, IMP-1Lily Mahapatra, Chengjian Mao, Neal Andruska, et al.
Journal of Biomolecular Screening|April 14, 2012
Evaluation of a luciferase-based reporter assay as a screen for inhibitors of estrogen-ERα-induced proliferation of breast cancer cellsNeal Andruska, Chengjian Mao, Mathew Cherian, et al.
Trends in Endocrinology and Metabolism: TEM|June 30, 2016
Anticipatory UPR Activation: A Protective Pathway and Target in CancerDavid J Shapiro, Mara Livezey, Liqun Yu, et al.
Translational Oncology|August 29, 2017
A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell ProliferationLily Mahapatra, Neal Andruska, Chengjian Mao, et al.
Advances in Radiation Oncology|February 1, 2021
The Novel Use of a Commercially Available Video-Conference Platform to Facilitate Multidisciplinary Target Volume Review and Delineation for Skull-Base Radiation Therapy During the Coronavirus Disease 2019 PandemicAmit Roy, Neal Andruska, Hilary L P Orlowski, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Opioid Management|December 19, 2019
Fentanyl analogue overdose: Key lessons in management in the synthetic opioid ageAmer Raheemullah, Neal Andruska
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 16, 2019
Cocaine Cessation for Levamisole-Induced Vasculitis: Treating the Underlying DiseaseAmer Raheemullah, Molly Melhem, Neal Andruska
Substance Use & Misuse|November 24, 2019
Improving Residency Education on Chronic Pain and Opioid Use Disorder: Evaluation of CDC Guideline-Based EducationAmer Raheemullah, Neal Andruska, Maryam Saeed, et al.
Molecular and Cellular Endocrinology|November 10, 2015
Anticipatory activation of the unfolded protein response by epidermal growth factor is required for immediate early gene expression and cell proliferationLiqun Yu, Neal Andruska, Xiaobin Zheng, et al.
BMJ Case Reports|October 11, 2018
Severe pneumonitis refractory to steroids following anti-PD-1 immunotherapyNeal Andruska, Lily Mahapatra, Carleigh Hebbard, et al.
Journal of Biomolecular Screening|October 11, 2013
High-throughput fluorescence anisotropy screen for inhibitors of the oncogenic mRNA binding protein, IMP-1Lily Mahapatra, Chengjian Mao, Neal Andruska, et al.
Journal of Biomolecular Screening|April 14, 2012
Evaluation of a luciferase-based reporter assay as a screen for inhibitors of estrogen-ERα-induced proliferation of breast cancer cellsNeal Andruska, Chengjian Mao, Mathew Cherian, et al.
Trends in Endocrinology and Metabolism: TEM|June 30, 2016
Anticipatory UPR Activation: A Protective Pathway and Target in CancerDavid J Shapiro, Mara Livezey, Liqun Yu, et al.
Translational Oncology|August 29, 2017
A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell ProliferationLily Mahapatra, Neal Andruska, Chengjian Mao, et al.
Advances in Radiation Oncology|February 1, 2021
The Novel Use of a Commercially Available Video-Conference Platform to Facilitate Multidisciplinary Target Volume Review and Delineation for Skull-Base Radiation Therapy During the Coronavirus Disease 2019 PandemicAmit Roy, Neal Andruska, Hilary L P Orlowski, et al.
Pageof 4